Dana Hu-Lowe
Corporate Officer/Principal en ADAGENE INC. .
Cargos activos de Dana Hu-Lowe
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/11/2021 | - |
Historial de carrera de Dana Hu-Lowe
Antiguos cargos conocidos de Dana Hu-Lowe.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TURG POIN | Director/Miembro de la Junta | 01/04/2019 | 01/10/2021 |
| Corporate Officer/Principal | 01/04/2019 | 01/10/2021 | |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 01/03/2013 | 01/03/2019 |
Formación de Dana Hu-Lowe.
| Beijing Normal University | Undergraduate Degree |
| University of Mississippi | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| China | 3 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
- Bolsa de valores
- Insiders
- Dana Hu-Lowe
- Experiencia